Guggenheim Capital LLC Amphastar Pharmaceuticals, Inc. Transaction History
Guggenheim Capital LLC
- $13.9 Billion
- Q2 2024
A detailed history of Guggenheim Capital LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 6,184 shares of AMPH stock, worth $300,109. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,184
Previous 4,611
34.11%
Holding current value
$300,109
Previous $202,000
22.28%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$288 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$130 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$94.4 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$82.1 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$78.7 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.38B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...